NASDAQ: RVMD - Revolution Medicines, Inc.

六个月盈利: -9.21%
股息率: 0.00%
部门: Healthcare

促销时间表 Revolution Medicines, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Revolution Medicines, Inc.

Revolution Medicines, Inc., компания, занимающаяся прецизионной онкологией, специализируется на разработке методов лечения, направленных на подавление мишеней, в первую очередь, в сигнальных путях RAS и mTOR. Основным кандидатом на продукт компании является RMC-4630, ингибитор SHP2, который находится в фазе 1b> F2 исследования для лечения РАС-зависимых опухолей. Его продукты на доклинической стадии включают мутантные белки RAS; SOS1, белок, который превращает RAS (OFF) в RAS (ON) в клетках; и RMC-5552, ингибитор mTORC1. Revolution Medicines, Inc.

更多详情
заключила соглашение о сотрудничестве с Санофи в области исследования и разработки ингибиторов SHP2. Компания была основана в 2014 году, ее штаб-квартира находится в Редвуд-Сити, штат Калифорния.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2020-02-13
ISIN US76155X1000
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.revmed.com
Цена ао 41.78
每日价格变化: -0.3646% (41.14)
每周价格变化: +1.74% (40.29)
每月价格变化: -7.66% (44.39)
3个月内价格变化: -11.7% (46.42)
六个月内的价格变化: -9.21% (45.15)
每年价格变化: +47.71% (27.75)
3年内价格变化: +84.89% (22.17)
5年内价格变化: 0% (40.99)
10年价格变化: 0% (40.99)
年初以来价格变化: -9.23% (45.16)
所有参数

低估

姓名 意义 年级
P/S 282.39 1
P/BV 1.79 8
P/E 0 0
EV/EBITDA -5.57 0
全部的: 3.5

效率

姓名 意义 年级
ROA, % -20.89 0
ROE, % -23.89 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.184 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -76.84 0
盈利能力 Ebitda, % 785.97 10
盈利能力 EPS, % 328.03 10
全部的: 8
更多详情

交易日期 披露日期 内幕 类型 价格 体积 数量 分享最多, % 之后分享, % 文档
21.01.2025 21.01.2025 JEFFREY TODD CISLINI
Officer		 购买 40.29 96 938 2406 0 0 关联
16.12.2024 16.12.2024 Kelsey Stephen Michael
Officer		 购买 44.93 206 858 4604 0 0.01 关联
16.12.2024 16.12.2024 GOLDSMITH MARK A
Officer		 购买 44.93 519 436 11561 0 0.02 关联
14.10.2024 16.10.2024 Kelsey Stephen Michael
See Remarks		 销售 49.49 824 800 16666 0 -0.02 关联
14.10.2024 16.10.2024 Kelsey Stephen Michael
See Remarks		 购买 4.09 68 164 16666 0 0.02 关联
16.09.2024 18.09.2024 Horn Margaret A
Chief Operating Officer		 销售 44.19 191 387 4331 0 -0.01 关联
16.09.2024 18.09.2024 GOLDSMITH MARK A
See Remarks		 销售 44.19 517 686 11715 0 -0.02 关联
16.09.2024 18.09.2024 Anders Jack
Chief Financial Officer		 销售 44.19 99 162 2244 0 0 关联
16.09.2024 16.09.2024 Anders Jack
Officer		 购买 42.12 77 164 1832 0 0 关联
15.07.2024 17.07.2024 Kelsey Stephen Michael
See Remarks		 销售 46.47 774 515 16667 0 -0.02 关联
15.07.2024 17.07.2024 Kelsey Stephen Michael
See Remarks		 购买 4.09 68 168 16667 0 0.02 关联
03.05.2024 03.05.2024 Anders Jack
Chief Financial Officer		 销售 40.03 400 300 10000 0 -0.01 关联
03.05.2024 03.05.2024 Anders Jack
Chief Financial Officer		 购买 2.68 26 800 10000 0 0.01 关联
10.04.2024 12.04.2024 Patel Sushil
Director		 销售 37 79 735 2155 0 0 关联
10.04.2024 12.04.2024 Patel Sushil
Director		 购买 16.8 36 204 2155 0 0 关联
27.03.2024 28.03.2024 Cislini Jeff
General Counsel		 销售 30.99 46 485 1500 0 0 关联
18.09.2023 20.09.2023 Anders Jack
Chief Financial Officer		 销售 31.31 44 679 1427 0 0 关联
18.09.2023 20.09.2023 Cislini Jeff
General Counsel		 销售 31.31 38 010 1214 0 0 关联
18.09.2023 20.09.2023 GOLDSMITH MARK A
See Remarks		 销售 31.31 252 171 8054 0 -0.01 关联
18.09.2023 20.09.2023 Kelsey Stephen Michael
See Remarks		 销售 31.31 64 499 2060 0 0 关联
10.03.2023 10.03.2023 Schroeder Thilo
Director		 购买 20.46 2 046 000 100000 0 0.14 关联
26.10.2022 28.10.2022 Horn Margaret A
See Remarks		 销售 20.15 358 025 17768 0 -0.02 关联
22.07.2022 26.07.2022 Schroeder Thilo
Director		 购买 20 5 000 000 250000 0 0.34 关联
08.06.2022 10.06.2022 Third Rock Ventures III, L.P.
10% Owner		 销售 20.25 8 503 000 419901 0 -0.57 关联
28.03.2022 29.03.2022 Schroeder Thilo
Director		 购买 24.71 17 915 725 0 0 关联
25.03.2022 29.03.2022 Schroeder Thilo
Director		 购买 24.79 1 041 180 42000 0 0.06 关联
17.09.2021 21.09.2021 Horn Margaret A
See Remarks		 销售 30.02 14 380 479 0 0 关联
17.09.2021 21.09.2021 GOLDSMITH MARK A
See Remarks		 销售 30.02 45 961 1531 0 0 关联
17.09.2021 21.09.2021 Wang Xiaolin
See Remarks		 销售 30.02 7 505 250 0 0 关联

机构 体积 分享, %
Wellington Management Group, LLP 14882086 9.04
Vanguard Group Inc 14634391 8.89
Blackrock Inc. 12954314 7.87
Farallon Capital Management Llc 6736854 4.09
Nextech Invest Ag 6296740 3.82
State Street Corporation 6253361 3.8
BVF Inc. 5981212 3.63
Casdin Capital, LLC 5714775 3.47
Alphabet Inc. 5301512 3.22
Baker Brothers Advisors, LLC 5148657 3.13

ETF 分享, % 本年盈利能力, % 股息, %
Tema Oncology ETF 3.12948 30.23 0.55
Range Cancer Therapeutics ETF 1.88416 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 0.90584 63.04 0.33
Future Tech ETF 0.73744 426.34 0.8416
Principal Healthcare Innovators ETF 0.73744 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.73389 28.58 0.8565
Direxion Daily S&P Biotech Bull 3x Shares 0.68928 4067.92 0.25924
John Hancock Multifactor Small Cap ETF 0.6588 16.88 1.54912
First Trust Mid Cap Growth AlphaDEX Fund 0.48748 26.95 0.9035
ProShares Ultra Nasdaq Biotechnology 0.48305 51.7 0.85651
iShares Russell 2000 Growth ETF 0.33385 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.31 23.05 0.60264
First Trust US Equity Opportunities ETF 0.29807 39.99 0.69524
Vanguard Russell 2000 ETF 0.24 17.16 1.48801
BNY Mellon US Mid Cap Core Equity ETF 0.19106 30.41 1.5641
First Trust Nasdaq BuyWrite Income ETF 0.18395 7.27 0.92977
iShares Morningstar Small Cap Value ETF 0.17568 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.17568 201.65 2.50476
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.17017 21.79 1.42082
Vanguard Russell 2000 Value ETF 0.17 12.26 2.37825
First Trust Mid Cap Core AlphaDEX Fund 0.16314 18.49 1.65423
Schwab U.S. Small-Cap ETF 0.15533 17.47 1.51433
ProShares UltraPro Russell2000 0.14951 89.82 1.47873
First Trust Multi Cap Growth AlphaDEX Fund 0.14682 41.56 1.02425
Goldman Sachs Innovate Equity ETF 0.14041 29.66 1.20987
Vanguard U.S. Momentum Factor ETF 0.14 30.05 1.05834
iShares Morningstar Small-Cap ETF 0.13634 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.13634 391.25 1.60498
iShares U.S. Tech Breakthrough Multisector ETF 0.1156 21.8 0.73986
iShares Morningstar Small-Cap Growth ETF 0.09999 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.09999 33.63 0.72598
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.09767 31.36 1.41955
iShares ESG Aware MSCI USA Small-Cap ETF 0.08147 18.09 1.49366
Vanguard Extended Market ETF 0.08 24.2 1.34786
Fidelity MSCI Health Care Index ETF 0.07732 3 1.46057
SoFi Next 500 ETF 0.07351 29.56 1.43041
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.04321 17.58 1.75869
ProShares Hedge Replication ETF 0.04096 5.92 1.47892
John Hancock Multifactor Mid Cap ETF 0.03841 20.65 1.52586
Humankind US Stock ETF 0.03035 18.81 1.99919
FlexShares Morningstar US Market Factor Tilt Index Fund 0.02173 21.94 1.69572
Dimensional U.S. Core Equity 2 ETF 0.01916 30.76 1.47098
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.0135 33 1.42661
iShares Russell 3000 ETF 0.0121 24.83 1.43482
Dimensional US Core Equity Market ETF 0.01188 30.98 1.40618
Schwab U.S. Broad Market ETF 0.01071 24.86 1.43354
Avantis U.S. Equity ETF 0.01011 23.04 1.59151
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0.01 23.54 1.26927
Dimensional U.S. Equity ETF 0.00411 31.53 1.3557
SPDR Portfolio MSCI Global Stock Market ETF 0.00267 17.99 2.19607
Convergence Long/Short Equity ETF -0.33179 32.85 1.56428



导师 职称 支付 出生年份
Mr. Jack Anders Chief Financial Officer 544.8k 1977 (48 年)
Mr. Walter Reiher Ph.D. Chief Information Officer N/A
Dr. Kevan M. Shokat Ph.D. Academic Co-Founder & Member of Scientific Advisory Board N/A
Dr. Mark A. Goldsmith Ph.D. CEO, President & Chairman 1.05M 1962 (63 年)
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. President of Research & Development 779k 1961 (64 年)
Ms. Margaret A. Horn J.D. Chief Operating Officer 775.6k 1963 (62 年)
Ms. Xiaolin Wang Executive Vice President of Development 604.1k 1971 (54 年)
Dr. Martin D. Burke M.D., Ph.D. Co-Founder & Chairman of Scientific Advisory Board N/A
Dr. Michael A. Fischbach Ph.D. Academic Co-Founder & Member of Scientific Advisory Board N/A 1981 (44 年)
Ms. Jan Smith Ph.D. Chief Scientific Officer N/A

地址: United States, Redwood City, CA , 700 Saginaw Drive - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.revmed.com